IL-27 is a therapeutic under development by our group for arthritis [1] and malignant tumors [2,3,4], on the basis of its multifunctional (immune stimulatory, anti-angiogenic, pro-osteogenic) activity. Here, IL27 is linked to arthritic joint disease.